Mitsubishi UFJ Trust & Banking’s Tango Therapeutics TNGX Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$132K	Buy	+4,222	New	+$104K	﹤0.01%	1458

Other funds holding TNGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

MGB

Mass General Brigham Somerville, Massachusetts $361M AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's TNGX Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 4,222 shares worth $132K. The stake represents ﹤0.01% of the portfolio and ranks #1458 among its holdings.

63 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 4,222 shares of Tango Therapeutics worth $132K as of Q2 2026.
Tango Therapeutics was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
Tango Therapeutics made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1458 holding.
63 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.